Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence PDAPRIKKIVQKKLAGDESAD
Primary information
sequence IDSeq_5887
Peptide sequencePDAPRIKKIVQKKLAGDESAD
CancerPDF_ID CancerPDF_ID101, CancerPDF_ID1097,
PMID16896061,16395409
Protein NamePlatelet Basic Protein Precursor,Platelet basic protein Precursor
UniprotKB Entry NameCXCL7_HUMAN,PPBP_HUMAN
FluidSerum,Serum
M/Z2279.18,2279.18
Charge1,1
Mass (in Da)2279.26,NA
fdrNA,NA
Profiling TechniqueMALDI-TOF,MALDI-TOF
Peptide Identification techniqueQ/TOF MS/MS,Q/TOF/TOF and LC-MS/MS
Quantification TechniqueNA,NA
Labelled/Label FreeLabel Free,Label Free
FDRNA,less than 1 “5
CancerPDF_ID CancerPDF_ID101, CancerPDF_ID1097,
p-Value1.00E-05,NA
SoftwareMASCOT,MASCOT (v 2.0.04 for Windows)
Length21,21
Cancer TypeMetastatic thyroid carcinomas,"Advanced Prostate, Breast and Bladder cancer"
DatabaseNCBI refseq Protein Database,NCBI refseq Protein Database
ModificationNA,NA
Number of Patients40 metastatic thyroid carcinoma patients and 40 normal for training phase and 10 metastatic thyroid carcinoma and 10 normal individuals for independent validation,"Advanced prostate (n = 32), breast (n = 21), and bladder (n = 20) cancer, 33 healthy in training test set, In validation set 41 independent serum samples from patients with advanced prostate cancer (prostate 2 [PR2])"
RegulationNA,NA
ValidationIndependent validation,Independent validation
Sensitivity95% on independent dataset,97.5% on independent validation dataset
Specificity95% on independent dataset,NA
AccuracyNA,97.5 % on validation dataset
Peptide AtlasPeptideAtlas
IEDB